Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma
Clinical trial NCT00185302 · COMPLETED
Trial details
- NCT number
- NCT00185302
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2006-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.